<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://innovox.news/news/marvell-lumentum-ai-optical-connectivity-deal</loc>
    <news:news>
      <news:publication>
        <news:name>INNOVOX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-02</news:publication_date>
      <news:title>Marvell’s $115 billion Lumentum deal puts optical links at the center of the AI buildout</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://innovox.news/news/upc-invalidates-enanta-paxlovid-patent</loc>
    <news:news>
      <news:publication>
        <news:name>INNOVOX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-02</news:publication_date>
      <news:title>UPC invalidates Enanta’s Paxlovid patent across 18 states—but its reasoning is not public</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://innovox.news/news/aramco-humain-ai-stake-three-gigawatt-target</loc>
    <news:news>
      <news:publication>
        <news:name>INNOVOX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-01</news:publication_date>
      <news:title>Aramco takes 49% of HUMAIN—but Saudi Arabia’s 3-gigawatt AI target still has to be built</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://innovox.news/news/australia-project-ares-ai-data-center-timeline</loc>
    <news:news>
      <news:publication>
        <news:name>INNOVOX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-01</news:publication_date>
      <news:title>Australia’s 1-gigawatt Project Ares drops its 2028 power target as environmental review expands</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://innovox.news/news/federal-circuit-chromadex-elysium-patent-fees</loc>
    <news:news>
      <news:publication>
        <news:name>INNOVOX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-01</news:publication_date>
      <news:title>Federal Circuit erases $9.15 million fee penalty—but ChromaDex’s vitamin B3 patents stay invalid</news:title>
    </news:news>
  </url>
</urlset>